Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q1 2023 Earnings Call Transcript May 9, 2023
Operator: Good afternoon, and welcome to the Mirati Therapeutics First Quarter 2023 Earnings Call. My name is Justin, and I will be the operator for today’s call. It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati. Ryan, you may begin the call.
Ryan Asay: Thank you, Justin, and welcome everyone to this afternoon’s call. Joining me on the call today are David Meek, our...
